Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Borderi

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Medical Virology|August 21, 2007
RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive menDavide Gibellini, Marco Borderi, Elisa De Crignis, et al.
Scandinavian Journal of Infectious Diseases|January 24, 2012
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancyLeonardo Calza, Roberto Manfredi, Filippo Trapani, et al.
The Journal of Infection|February 16, 2008
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individualsDavide Gibellini, Marco Borderi, Elisa De Crignis, et al.
Journal of Medical Virology|July 24, 2008
HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activationDavide Gibellini, Elisa De Crignis, Cristina Ponti, et al.
AIDS Research and Human Retroviruses|January 17, 2017
Dual Raltegravir-Etravirine Combination as Maintenance Regimen in Virologically Suppressed HIV-1-Infected PatientsLeonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
The New Microbiologica|July 8, 2009
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infectionCarlo Biagetti, Isabella Bon, Francesca Vitone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2015
Recommendations for evaluation and management of bone disease in HIVTodd T Brown, Jennifer Hoy, Marco Borderi, et al.
AIDS Research and Human Retroviruses|November 5, 2014
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort studyLeonardo Calza, Ilaria Danese, Vincenzo Colangeli, et al.
Infectious Diseases (London, England)|June 21, 2019
Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver diseaseLeonardo Calza, Vincenzo Colangeli, Marco Borderi, et al.
The New Microbiologica|July 16, 2019
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control studyLeonardo Calza, Giulia di Pietro, Vincenzo Colangeli, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Medical Virology|August 21, 2007
RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive menDavide Gibellini, Marco Borderi, Elisa De Crignis, et al.
Scandinavian Journal of Infectious Diseases|January 24, 2012
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancyLeonardo Calza, Roberto Manfredi, Filippo Trapani, et al.
The Journal of Infection|February 16, 2008
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individualsDavide Gibellini, Marco Borderi, Elisa De Crignis, et al.
Journal of Medical Virology|July 24, 2008
HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activationDavide Gibellini, Elisa De Crignis, Cristina Ponti, et al.
AIDS Research and Human Retroviruses|January 17, 2017
Dual Raltegravir-Etravirine Combination as Maintenance Regimen in Virologically Suppressed HIV-1-Infected PatientsLeonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
The New Microbiologica|July 8, 2009
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infectionCarlo Biagetti, Isabella Bon, Francesca Vitone, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2015
Recommendations for evaluation and management of bone disease in HIVTodd T Brown, Jennifer Hoy, Marco Borderi, et al.
AIDS Research and Human Retroviruses|November 5, 2014
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort studyLeonardo Calza, Ilaria Danese, Vincenzo Colangeli, et al.
Infectious Diseases (London, England)|June 21, 2019
Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver diseaseLeonardo Calza, Vincenzo Colangeli, Marco Borderi, et al.
The New Microbiologica|July 16, 2019
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control studyLeonardo Calza, Giulia di Pietro, Vincenzo Colangeli, et al.
Pageof 7